Assertio Holdings Inc (NASDAQ:ASRT) reports a slight increase in net product sales year over year for Q3 2023.
Significant non-cash charges lead to a net loss for the quarter, contrasting with the net income of the same period last year.
Management changes announced alongside strategic steps to address current business challenges.
Assertio Holdings Inc (NASDAQ:ASRT), a specialty pharmaceutical company, released its financial results for the third quarter ended September 30, 2023, on November 8, 2023. The company faced several challenges during the quarter, including the loss of Indocin exclusivity and lower-than-expected results from Rolvedon, which led to substantial charges impacting net income.
https://finance.yahoo.com/news/assertio-holdings-inc-asrt-faces-234633903.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.